Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.9B | 11.8B | 13.1B | 12.3B |
Cost of revenue | 12.8B | 9.3B | 10.9B | 9.9B |
Gross profit | 3.1B | 2.5B | 2.2B | 2.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 971.2M | 681.5M | 703.7M | 652.9M |
Operating income | 1.6B | 1.3B | 941.3M | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 5M | 3.9M | 3.8M | 4M |
Other income expense | — | — | — | — |
Pretax income | 2.6B | 1.9B | 1.5B | 3.2B |
Tax provision | 697.5M | 453.1M | 327.9M | 738.3M |
Net income | 1.9B | 1.5B | 1.2B | 2.4B |
Basic EPS | — | 9.6 | 7.7 | 16.0 |
Diluted EPS | — | 9.6 | 7.7 | 16.0 |
Basic average shares | — | 152.9M | 152.9M | 152.9M |
Diluted average shares | — | 152.9M | 152.9M | 152.9M |
EBITDA | 2.7B | 2.0B | 1.6B | 3.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |